You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永安藥業(002365.SZ):一季度扣非淨利潤預增1174.47%-1284.71%
格隆匯 04-13 16:48

格隆匯4月13日丨永安藥業(002365.SZ)公佈2022年第一季度業績預吿,公司預計實現歸屬於上市公司股東的淨利潤為4863.43萬元-5255.64萬元,同比增長520.00%-570.00%;預計實現扣除非經常性損益後的淨利潤為4534.45萬元-4926.66萬元,同比增長1174.47%-1284.71%。

預計2022年第一季度業績同比大幅增長的主要原因是:(1)報吿期內,公司主要產品牛磺酸市場需求旺盛,銷售價格較上年同期顯著上漲;(2)由於2021年第一季度歸屬於上市公司股東的淨利潤基數較低,2022年第一季度業績相比大幅增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account